Imidafenacin
- Generic Name
- Imidafenacin
- Drug Type
- Small Molecule
- Chemical Formula
- C20H21N3O
- CAS Number
- 170105-16-5
- Unique Ingredient Identifier
- XJR8Y07LJO
Overview
Imidafenacin is an antispasmodic agent with anticholinergic effects. It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment of overactive bladder. It is marketed in Japan under the tradenames Staybla by Ono Pharmaceutical and Uritos by Kyojin Pharmaceutical.
Background
Imidafenacin is an antispasmodic agent with anticholinergic effects. It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment of overactive bladder. It is marketed in Japan under the tradenames Staybla by Ono Pharmaceutical and Uritos by Kyojin Pharmaceutical.
Indication
临床用于缓解膀胱过度活动症伴随的急迫性尿失禁、尿急、尿频症状。
Associated Conditions
- Overactive Bladder Syndrome (OABS)
- Urinary Incontinence (UI)
- Urinary Urge Incontinence
- Urinary Urgency
- Increased frequency of urination
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath